An integrated pathway interaction network for the combination of four effective compounds from ShengMai preparations in the treatment of cardio-cerebral ischemic diseases

AIM: SMXZF (a combination of ginsenoside Rb1, ginsenoside Rg1, schizandrin and DT-13) derived from Chinese traditional medicine formula ShengMai preparations) is capable of alleviating cerebral ischemia-reperfusion injury in mice. In this study we used network pharmacology approach to explore the me...

Full description

Saved in:
Bibliographic Details
Published in:Acta Pharmacol Sin
Main Authors: Li, Fang, Lv, Yan-ni, Tan, Yi-sha, Shen, Kai, Zhai, Ke-feng, Chen, Hong-lin, Kou, Jun-ping, Yu, Bo-yang
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2015
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4635328/
https://ncbi.nlm.nih.gov/pubmed/26456587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2015.70
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items